Your browser doesn't support javascript.
loading
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.
van Dyk, Madelé; Kapetas, Asha J; Hopkins, Ashley M; Rodrigues, A David; Vourvahis, Manoli; Sorich, Michael J; Rowland, Andrew.
Affiliation
  • van Dyk M; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Kapetas AJ; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Rodrigues AD; ADME Sciences, Medicine Design, Pfizer Inc, Groton, CT, United States.
  • Vourvahis M; Clinical Pharmacology, Global Product Development, Pfizer Inc, New York, NY, United States.
  • Sorich MJ; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Rowland A; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Front Pharmacol ; 10: 1120, 2019.
Article in En | MEDLINE | ID: mdl-31611799
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Australia Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Australia Country of publication: Suiza